Evidence map›Paper›PMID 19828168›Full record

ArticleSurgery2010

The utility of [(11)C] dihydrotetrabenazine positron emission tomography scanning in assessing beta-cell performance after sleeve gastrectomy and duodenal-jejunal bypass.

William B Inabnet, Luca Milone, Paul Harris, Evren Durak, Matthew J Freeby, Leaque Ahmed, Manu Sebastian, Jean-Christophe Lifante, Marc Bessler, Judith Korner

Open access · greenAbstract read
In one paragraph

Article in Surgery, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. New Insights and Potential Therapeutic Interventions in Metabolic Diseases.International journal of molecular sciences · 2023
    Review
  2. Review
  3. Review
  4. Intravital imaging of islet CaNature communications · 2021
    Article
  5. Review
  6. Article
  7. Article
  8. Molecular imaging of β-cells: diabetes and beyond.Advanced drug delivery reviews · 2019
    Review
  9. Observational
  10. Article
  11. Article
  12. Anti-incretin, Anti-proliferative Action of Dopamine on β-Cells.Molecular endocrinology (Baltimore, Md.) · 2015
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

William B InabnetDivision of Metabolic, Endocrine and Minimally Invasive Surgery, Department of Surgery, Mount Sinai Medical Center, New York, NY 10029, USA. william.inabnet@mountsinai.org
Luca Milone
Paul Harris
Evren Durak
Matthew J Freeby
Leaque Ahmed
Manu Sebastian
Jean-Christophe Lifante
Marc Bessler
Judith Korner
Columbia University · USMount Sinai Medical Center · US

Funding

Human Islet Antigen Discovery and ImagingR01DK063567 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HARRIS, PAUL E · 2002 to 2012
$2.7M
PET imaging of human beta cell massR01DK077493 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HARRIS, PAUL E · 2006 to 2008
$1.7M
NIDDK NIH HHS R01 DK063567NIDDK NIH HHS R01 DK077493
6 · The paper itself

Abstract

backgroundThe aim of this study was to evaluate the effect of sleeve gastrectomy (SG) and duodenal-jejunal bypass (DJB) on glucose homeostasis and to evaluate the utility of positron emission tomography (PET) scanning for assessing beta-cell mass.

methodsGoto-Kakizaki rats were divided into 4 groups: control, sham, SG, or DJB. Oral glucose tolerance, insulin, and glucagon-like peptide-1 (GLP-1) were measured before and after surgery. Before and 90 days after treatment, [(11)C] DTBZ micro PET scanning was performed.

resultsThe control and sham animals gained more weight compared with SG and DJB animals (P < or = .05). Compared with control animals, the glucose area under the curve was lower in DJB animals 30 and 45 days after operations (P < or = .05). At killing, GLP-1 levels were greater in the DJB group compared with sham and SG (P < or = .05), whereas insulin levels were greater in both DJB and SG compared with sham (P < or = .05). With PET scanning, the 90-day posttreatment mean vesicular monoamine transporter type 2 binding index was greatest in the DJB animals (2.45) compared with SG (1.17), both of which were greater than baseline control animals (0.81).

conclusionIn type 2 diabetic rodents, DJB leads to improved glucose homeostasis and an increase in VMAT2 density as measured by PET scanning.

Indexed as

Bariatric SurgeryCarbon RadioisotopesGastrectomyPositron-Emission TomographyAnimalsDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2DuodenumGlucagon-Like Peptide 1GlucoseGlucose Tolerance TestHomeostasisInsulinInsulin-Secreting CellsJejunumRatsCarbon RadioisotopesdihydrotetrabenazineGlucagon-Like Peptide 1GlucoseInsulinSlc18a2 protein, ratTetrabenazineVesicular Monoamine Transport Proteins

Identifiers

PMID19828168
PMCPMC3620030
OpenAlexW1987313693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.